pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase

  • 1.

    Levey, A., Lah, J., Goldstein, F., Steenland, K. & Bliwise, D. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer’s disease. Clin. Ther. 28, 991–1001 (2006).

  • 2.

    Lin, C. H., Huang, Y. J., Lin, C. J., Lane, H. Y. & Tsai, G. E. NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer’s disease. Current pharmaceutical design 20, 5169–5179 (2014).

  • 3.

    McDonald, J. W. & Johnston, M. V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev 15, 41–70 (1990).

  • 4.

    Lin, C. H., Yang, H. T., Chiu, C. C. & Lane, H. Y. Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging. Scientific reports 7, 14849 (2017).

  • 5.

    Butterfield, D. A. & Boyd-Kimball, D. Redox Proteomics and Amyloid beta-Peptide: Insights into…

  • Read more…